Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-10-30 19:18 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,350
+2,500 vol $1.34 each |
26,499 | |
Filed 2023-10-30 19:16 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: FRR Conjoint (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-3,000 vol |
1,000 | |
Filed 2023-10-30 19:13 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-72,001 vol |
23,999 | |
Filed 2023-10-30 17:37 Tx date 2023-06-30 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: Ginette Anfosse (Indirect Ownership)
|
Convertible Notes
38 - Redemption, retraction, cancellation, repurchase
|
-$15,000 vol |
$0 | |
Filed 2023-10-30 17:32 Tx date 2023-06-30 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
38 - Redemption, retraction, cancellation, repurchase
|
-$30,000 vol |
$0 | |
Filed 2023-03-04 17:00 Tx date 2023-02-28 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,043
+21,739 vol $1.29 each |
105,913 | |
Filed 2021-12-04 18:35 Tx date 2021-12-01 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,655
+14,170 vol $4.21 each |
84,174 | |
Filed 2021-02-28 18:23 Tx date 2021-02-26 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,103
+13,258 vol $3.93 each |
70,004 | |
Filed 2021-02-28 18:08 Tx date 2020-11-27 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-47,500
-10,000 vol $4.75 each |
56,746 | |
Filed 2020-02-27 11:12 Tx date 2020-02-26 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,600 vol |
66,746 | |
Filed 2019-03-01 Tx date 2019-02-26 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+8,900 vol |
56,146 | |
Filed 2018-10-14 Tx date 2018-10-09 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,000
-5,000 vol $1.80 each |
57,246 | |
Filed 2018-10-14 Tx date 2018-10-09 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,400
-10,000 vol $1.84 each |
47,246 | |
Filed 2018-10-14 Tx date 2018-10-09 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,000
+5,000 vol $1.80 each |
86,000 | |
Filed 2018-10-14 Tx date 2018-10-09 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,400
+10,000 vol $1.84 each |
96,000 | |
Filed 2018-06-26 Tx date 2018-06-19 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
15 - Acquisition or disposition under a prospectus
|
+$15,000 vol |
||
Filed 2018-06-26 Tx date 2018-06-19 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
15 - Acquisition or disposition under a prospectus
|
+$30,000 vol |
$30,000 | |
Filed 2018-06-22 Tx date 2006-02-08 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: Ginette Anfosse (Indirect Ownership)
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-22 Tx date 2018-06-19 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: Ginette Anfosse (Indirect Ownership)
|
Convertible Notes
15 - Acquisition or disposition under a prospectus
|
+$15,000 vol |
$15,000 | |
Filed 2018-06-22 Tx date 2006-02-08 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-22 Tx date 2018-06-19 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
15 - Acquisition or disposition under a prospectus
|
+$15,000 vol |
$15,000 | |
Filed 2018-04-09 Tx date 2017-04-20 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,000 vol |
40,000 | |
Filed 2018-04-09 Tx date 2018-04-06 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,246 vol |
62,246 | |
Filed 2017-10-18 Tx date 2017-10-16 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Unités d'actions différées (DSU)
56 - Grant of rights
|
$15,000
+1,894 vol $7.92 each |
21,936 | |
Filed 2017-05-17 Tx date 2017-05-16 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
60,000 | |
Filed 2016-07-15 Tx date 2016-07-12 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
45,000 | |
Filed 2016-07-15 Tx date 2016-07-12 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
||
Filed 2016-07-13 Tx date 2016-07-12 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
45,000 | |
Filed 2016-07-08 Tx date 2016-07-07 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: FRR Conjoint (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,440
+4,000 vol $2.36 each |
4,000 | |
Filed 2016-07-07 Tx date 2006-02-08 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Holder: FRR Conjoint (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-05-11 Tx date 2016-04-14 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,300
-5,000 vol $1.86 each |
30,000 | |
Filed 2015-06-28 Tx date 2015-06-26 |
$TH
Theratechnologies Inc. |
Lacoste, Gérald A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,700
+10,000 vol $1.47 each |
81,000 |